The medical technology company Synthetic MR's rights issue was subscribed to 98.6 percent with and without subscription rights. As a result, guarantee commitments concerning 417,786 shares from Staffan Persson, via Swedia Invest, corresponding to the remaining 1.4 percent of the intended issue volume, will be utilized. The rights issue was thereby fully subscribed, according to a press release. The company will receive SEK 32.8 million before issue costs. The number of outstanding shares increases by 29.78 million and thereafter amounts to 89.33 million shares.